Cargando…
Dual Antiplatelet Therapy Using Cilostazol With Aspirin or Clopidogrel: Subanalysis of the CSPS.com Trial
BACKGROUND AND PURPOSE: Although dual antiplatelet therapy (DAPT) with aspirin and clopidogrel reduces the recurrence of ischemic stroke while significantly increasing the bleeding events compared with monotherapy, the CSPS.com trial (Cilostazol Stroke Prevention Study combination) showed that DAPT...
Autores principales: | Hoshino, Haruhiko, Toyoda, Kazunori, Omae, Katsuhiro, Ishida, Noriyuki, Uchiyama, Shinichiro, Kimura, Kazumi, Sakai, Nobuyuki, Okada, Yasushi, Tanaka, Kortaro, Origasa, Hideki, Naritomi, Hiroaki, Houkin, Kiyohiro, Yamaguchi, Keiji, Isobe, Masanori, Minematsu, Kazuo, Matsumoto, Masayasu, Tominaga, Teiji, Tomimoto, Hidekazu, Terayama, Yasuo, Yasuda, Satoshi, Yamaguchi, Takenori |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8547582/ https://www.ncbi.nlm.nih.gov/pubmed/34404237 http://dx.doi.org/10.1161/STROKEAHA.121.034378 |
Ejemplares similares
-
Sex Difference in the Impact of Dual Antiplatelet Therapy using Cilostazol for Secondary Stroke Prevention: A Sub-Analysis of CSPS.com
por: Hoshino, Haruhiko, et al.
Publicado: (2023) -
Protocol for Cilostazol Stroke Prevention Study for Antiplatelet Combination (CSPS.com): a randomized, open-label, parallel-group trial
por: Toyoda, Kazunori, et al.
Publicado: (2015) -
Dual Antiplatelet Therapy Using Cilostazol in Patients With Stroke and Intracranial Arterial Stenosis
por: Uchiyama, Shinichiro, et al.
Publicado: (2021) -
Association of Timing for Starting Dual Antiplatelet Treatment With Cilostazol and Recurrent Stroke: A CSPS.com Trial Post Hoc Analysis
por: Toyoda, Kazunori, et al.
Publicado: (2022) -
Adjunctive Cilostazol versus High Maintenance Dose of Clopidogrel in Patients with Hyporesponsiveness to Chronic Clopidogrel Therapy
por: Lee, Ga Yeon, et al.
Publicado: (2013)